Tag: drug discovery
Biobank and Pharma Services now have Commercial Access to Lifespin’s Metabolic Profiler Software and...
Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced that it has launched a new commercial service for the pharmaceutical and biobanking industry to assist companies in key phases of research, development, and manufacturing.
Immediate applications of...
New Freezing Technique for Ready-to-Use Cells in Research Validated by University of Warwick and...
A new technique for freezing cells for use in biomedical research, based on polymer technology developed at the University of Warwick, has been validated in study, paving the way for faster results for scientists in their research.
Cells attached as...
Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges
Recent scientific advancements have made stem cell therapy an emerging and promising area of research. The establishment of stem cell banks around the globe has been growing rapidly, aimed at preserving the characteristics of the cells, preventing contamination, and...
Sample Management Specialists Win Queen’s Award for Enterprise
UK Small Business Minister Paul Scully said "This country is renowned for its entrepreneurial achievements and there is no greater showcase for it than The Queen's Awards. It is vital we celebrate the success of our businesses and recognise...
Lifebit and Boehringer Ingelheim Partner Up to Maximize the Value of Biobank Data for...
Computational science is revolutionizing the world in many ways. Hundreds of new fields and disciplines have emerged with countless opportunities and possibilities. The digital revolution has reached all sectors of modern society, including biomedical research and health care. Almost...
Datavant Partners with Nashville Biosciences to Accelerate Drug Discovery and Clinical Research
Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC) that leverages BioVU®, the medical center’s de-identified biobank to support biopharma research and development, and Datavant, the leader in securely connecting the world’s health data, today announced a...
Targeting CK1δ In Bladder Cancer
According to data from the US National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program, the 5-year survival rates, 2000-2016, for invasive bladder cancer were approximately 70% for localized cancer, 35% for regional, and 6% for metastatic bladder...
Broad And Sanger Reproduce CRISPR-Cas9 Genetic Knock-Out Screens In 725 Cancer Cell Line Models
A comprehensive map of genes necessary for cancer survival
is one step closer, following the validation of the two largest CRISPR-Cas9
genetic screens in 725 cancer models across 25 different cancer types.
Scientists at the Wellcome Sanger Institute and the Broad Institute...
Crown Bioscience Teams Up With HUB To Launch Tumor Organoid Drug Development Platform
Crown Bioscience has launched a new tumor organoid drug
development platform with the potential to significantly improve the
predictivity and speed of preclinical drug discovery. Independently founded in 2006, Crown Bioscience, now a JSR
Life Sciences company, a business unit of JSR Corporation,...
A:Head Bio AG Incorporated To Use Cerebral Organoids For CNS Drug Discovery
a:head bio AG, an Austrian biotech company focused on the
development of next generation therapeutics for the treatment of brain
disorders based on human cerebral organoids has recently been incorporated. The
new venture is based on groundbreaking technology developed at the Institute...
